The individualized nature of tumors requires genomic testing for providing the best outcomes for patients. Next-Gen Sequencing enables the detection of small mutations, copy number changes, and common fusions affordably and with high precision. However, the interpretation of these detected variants is arduous without a comprehensive analytical workflow that can incorporate all the bioinformatic and clinical evidence involved in following the AMP guidelines for the scoring and reporting of somatic mutations.
Building on the success of VSClinical’s ACMG guidelines, the new VSClinical AMP guidelines enables new and existing labs to provide genetic tests for cancer efficiently and with a focus on delivering consistent and accurate results.
To celebrate this exciting product enhancement, we will be upgrading all one-year license orders of VSClinical +Cancer Add-On to a 15-month license! This offer will be expiring on June 30th.
One license of VSClinical +AMP Guidelines
*After applicable discounts*
Our team is ready to discuss these specials with you today! Enter your information below, and we will be in touch shortly. If you do not see a form, please email us here.